16049057 19759061 18804122 18172611 27358027 15640278 25386825 27168137 16809436 16286564 17085538 31506648 18923190 26138553 17430129 20051229 20675563 22184324 24732892 19194560 28694144 17098828 26010093 18178728 16788004 32674346 19830780 1825036 - Search Results

Year	Number of Results
2005	5
2006	5
2007	4
2008	8
2009	4
2010	9
2011	2
2012	2
2013	1
2014	1
2015	4
2016	2
2017	1
2019	1
2020	2
2021	1
2022	0

1

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ, Ferrario CM, Raizada MK. Huentelman MJ, et al. Exp Physiol. 2005 Sep;90(5):783-90. doi: 10.1113/expphysiol.2005.031096. Epub 2005 Jul 27. Exp Physiol. 2005. PMID: 16049057 Free article.

2

Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology.

Funke-Kaiser H, Reinemund J, Steckelings UM, Unger T. Funke-Kaiser H, et al. J Renin Angiotensin Aldosterone Syst. 2010 Mar;11(1):7-17. doi: 10.1177/1470320309343652. Epub 2009 Sep 16. J Renin Angiotensin Aldosterone Syst. 2010. PMID: 19759061 Free article. Review.

3

AT2 receptors: functional relevance in cardiovascular disease.

Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. Jones ES, et al. Pharmacol Ther. 2008 Dec;120(3):292-316. doi: 10.1016/j.pharmthera.2008.08.009. Epub 2008 Aug 31. Pharmacol Ther. 2008. PMID: 18804122 Free PMC article. Review.

4

Brain angiotensin receptors and binding proteins.

Speth RC, Karamyan VT. Speth RC, et al. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):283-93. doi: 10.1007/s00210-007-0238-7. Epub 2008 Jan 3. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18172611 Review.

5

Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.

Chow BS, Allen TJ. Chow BS, et al. Clin Sci (Lond). 2016 Aug 1;130(15):1307-26. doi: 10.1042/CS20160243. Clin Sci (Lond). 2016. PMID: 27358027 Review.

6

Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension.

Katovich MJ, Grobe JL, Huentelman M, Raizada MK. Katovich MJ, et al. Exp Physiol. 2005 May;90(3):299-305. doi: 10.1113/expphysiol.2004.028522. Epub 2005 Jan 7. Exp Physiol. 2005. PMID: 15640278 Free article. Review.

7

New antihypertensive drugs under development.

Tamargo J, Duarte J, Ruilope LM. Tamargo J, et al. Curr Med Chem. 2015;22(3):305-42. doi: 10.2174/0929867321666141106113018. Curr Med Chem. 2015. PMID: 25386825 Review.

8

The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.

Chow BS, Koulis C, Krishnaswamy P, Steckelings UM, Unger T, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Chow BS, et al. Diabetologia. 2016 Aug;59(8):1778-90. doi: 10.1007/s00125-016-3977-5. Epub 2016 May 11. Diabetologia. 2016. PMID: 27168137

9

Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II.

Li H, Gao Y, Freire CD, Raizada MK, Toney GM, Sumners C. Li H, et al. FASEB J. 2006 Aug;20(10):1748-50. doi: 10.1096/fj.06-5836fje. Epub 2006 Jun 29. FASEB J. 2006. PMID: 16809436

10

The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.

D'Amore A, Black MJ, Thomas WG. D'Amore A, et al. Hypertension. 2005 Dec;46(6):1347-54. doi: 10.1161/01.HYP.0000193504.51489.cf. Epub 2005 Nov 14. Hypertension. 2005. PMID: 16286564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results